How have RLM shares performed in 2024?

Realm Therapeutics' stock was trading at GBX 11.50 at the beginning of 2024. Since then, RLM stock has increased by 0.0% and is now trading at GBX 11.50. View the best growth stocks for 2024 here .

What other stocks do shareholders of Realm Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Realm Therapeutics investors own include Allena Pharmaceuticals (ALNA) , AcelRx Pharmaceuticals (ACRX) , Ampliphi Biosciences (APHB) , Viking Therapeutics (VKTX) , Arbutus Biopharma (ABUS) , Aurora Cannabis (ACBFF) , Aldeyra Therapeutics (ALDX) , Apellis Pharmaceuticals (APLS) .

How do I buy shares of Realm Therapeutics?

Shares of RLM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:RLM

Realm Therapeutics (RLM) Share Price, News & Analysis

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Free RLM Stock Alerts

GBX 11.50

0.00 (0.00%)

(As of 03/26/2019)

Compare

Today's Range: 11.50
▼
11.50
50-Day Range: 11.50
▼
11.50
52-Week Range: 5.80
▼
40

Volume: 169,853 shs
Average Volume: 800,861 shs
Market Capitalization: £13.40 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Realm Therapeutics alerts:

Ad Wall Street Star

This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

About Realm Therapeutics

Realm Therapeutics Plc, a biopharmaceutical company, focuses on developing therapies for the treatment of immune-mediated diseases in adults and children. Its product pipeline includes PRO22, a topical gel, which is conducting initial Phase II clinical studies for the treatment of atopic dermatitis. The company was formerly known as PuriCore plc and changed its name to Realm Therapeutics Plc in December 2016. Realm Therapeutics Plc was founded in 2016 and is headquartered in Malvern, Pennsylvania.

RLM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RLM Stock News Headlines

May 24, 2023 | washingtonpost.com

A watery mythological realm is given flesh at the Smithsonian

March 23, 2023 | bbc.co.uk

Defence of the Realm Act (DORA)

April 23, 2024 | TradeSmith (Ad)

The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

February 28, 2022 | investing.com

Realm Therapeutics PLC ADR (RLM_old)

See More Headlines

Receive RLM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Realm Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:RLM
Previous Symbol: LON:PURI
CUSIP: N/A
CIK: N/A
Web: www.realmtx.com
Phone: +1-484-3212700
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 10.05
Quick Ratio: 9.96

Sales & Book Value

Annual Sales: £501,919.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 0.57
Book Value: GBX 20.80 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 116,562,000
Free Float: N/A
Market Cap: £13.41 million
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. John Alexander Martin (Age 51)
CEO & Exec. Director
Ms. Marella Thorell (Age 52)
CFO, COO, Company Sec. & Exec. Director
Dr. Christian Peters (Age 57)
Chief Medical Officer

Key Competitors

View All Competitors

RLM Stock Analysis - Frequently Asked Questions

How have RLM shares performed in 2024?: Realm Therapeutics' stock was trading at GBX 11.50 at the beginning of 2024. Since then, RLM stock has increased by 0.0% and is now trading at GBX 11.50.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Realm Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Realm Therapeutics investors own include Allena Pharmaceuticals (ALNA), AcelRx Pharmaceuticals (ACRX), Ampliphi Biosciences (APHB), Viking Therapeutics (VKTX), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS).
How do I buy shares of Realm Therapeutics?: Shares of RLM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:RLM) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial